Literature DB >> 7733886

Molecular cloning, purification and in situ localization of human colon kallikrein.

L M Chen1, G P Richards, L Chao, J Chao.   

Abstract

We have cloned and characterized a full-length cDNA encoding tissue kallikrein from a human colon carcinoma cell line (T84). The nucleic acid sequence of the colon kallikrein cDNA is identical to that of renal/pancreatic or tissue kallikrein cDNA. Reverse-transcription PCR followed by Southern-blot analysis using specific oligonucleotide probes showed expression of tissue kallikrein in human colon, pancreas and kidney. Tissue kallikrein mRNA was localized in glandular epithelial cells (goblet cells) in colon by in situ hybridization histochemistry. Human colon kallikrein was purified to apparent homogeneity by DEAE-Sepharose Cl-6B, aprotinin-affinity, and HQ/M perfusion chromatography. The purified colon kallikrein migrated as a broad, 40-45 kDa band in SDS/PAGE and was recognized by antibodies to human tissue kallikrein. The linear displacement curves for the colon kallikrein in an RIA were parallel with the human tissue kallikrein standard curve, indicating their immunological identity. The N-terminal sequence of the purified colon kallikrein matches completely with that of purified urinary or tissue kallikrein. These results indicate that human colon kallikrein is transcribed from the tissue kallikrein gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733886      PMCID: PMC1136673          DOI: 10.1042/bj3070481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Enhancement of kallikrein production and kinin sensitivity in T84 cells by growth in the nude mouse.

Authors:  A W Baird; D H Miller; D A Schwartz; H S Margolius
Journal:  Am J Physiol       Date:  1991-11

Review 4.  Kallikreins (kininogenases)--a group of serine proteases with bioregulatory actions.

Authors:  M Schachter
Journal:  Pharmacol Rev       Date:  1979-03       Impact factor: 25.468

5.  Kallikrein-gene expression in the rat gastrointestinal tract.

Authors:  P J Fuller; K Verity; B A Matheson; J A Clements
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 6.  The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation.

Authors:  J A Clements
Journal:  Endocr Rev       Date:  1989-11       Impact factor: 19.871

7.  New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.

Authors:  T Morita; H Kato; S Iwanaga; K Takada; T Kimura
Journal:  J Biochem       Date:  1977-11       Impact factor: 3.387

8.  Characterization of the human kallikrein locus.

Authors:  P H Riegman; R J Vlietstra; L Suurmeijer; C B Cleutjens; J Trapman
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

9.  Molecular cloning and sequence analysis of the monkey and human tissue kallikrein genes.

Authors:  F K Lin; C H Lin; C C Chou; K Chen; H S Lu; W Bacheller; C Herrera; T Jones; J Chao; L Chao
Journal:  Biochim Biophys Acta       Date:  1993-06-25

10.  Similarity between a kininogenase (kallikrein) from human large intestine and human urinary kallikrein.

Authors:  A Zimmermann; R Geiger; H Kortmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12
View more
  6 in total

1.  Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.

Authors:  B A Katz; B Liu; M Barnes; E B Springman
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

2.  A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Authors:  W C Wolf; D M Evans; L Chao; J Chao
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Tissue kallikrein in human placenta in early and late gestation.

Authors:  G Valdés; C Chacón; J Corthorn; C D Figueroa; A M Germain
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

4.  Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation.

Authors:  G Valdés; A M Germain; J Corthorn; C Chacón; C D Figueroa; W Müller-Esterl
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

5.  Recombinant hirustasin: production in yeast, crystallization, and interaction with serine proteases.

Authors:  S Di Marco; G Fendrich; R Knecht; A Strauss; G Pohlig; J Heim; J P Priestle; C P Sommerhoff; M G Grütter
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

6.  Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease.

Authors:  Antoni Stadnicki; Urszula Mazurek; Maciej Gonciarz; Danuta Plewka; Grazyna Nowaczyk; Joanna Orchel; Ezbieta Pastucha; Andrzej Plewka; Tadcusz Wilczok; Robert W Colman
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.